Two Novel Fully Functional Isoforms of CX3CR1 Are Potent HIV Coreceptors

Journal of Immunology

Volumn 171, Issue 10, 2003, Pages 5305-5312

  Garin, Alexandre ^a   Tarantino, Nadine ^a   Faure, Sophie ^a   Daoudi, Mehdi ^a   Lécureuil, Cédric ^a   Bourdais, Anne ^a   Debré, Patrice ^a   Deterre, Philippe ^a   Combadiere, Christophe ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CX3R1; CX3CL1 CHEMOKINE; ISOPROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG; VIRUS RECEPTOR;

ALTERNATIVE RNA SPLICING; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING KINETICS; CALCIUM MOBILIZATION; CELL ACTIVATION; CHEMOTAXIS; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIGAND BINDING; MOLECULAR RECOGNITION; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STEADY STATE; T LYMPHOCYTE; VIRUS ENVELOPE;

EID: 0242578818     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.10.5305     Document Type: Article

References (49)

1. Murphy, P. M. 1994. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12:593.
2. Luster, A. D. 1998. Chemokines: chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:436.
3. Baggiolini, M. 2001. Chemokines in pathology and medicine. J. Intern. Med. 250:91.
4. LaRosa, G. J., K. M. Thomas, M. E. Kaufmann, R. Mark, M. White, L. Taylor, G. Gray, D. Witt, and J. Navarro. 1992. Amino terminus of the interleukin-8 receptor is a major determinant of receptor subtype specificity. J. Biol. Chem. 267:25402.
5. Hebert, C. A., A. Chuntharapai, M. Smith, T. Colby, J. Kim, and R. Horuk. 1993. Partial functional mapping of the human interleukin-8 type A receptor: identification of a major ligand binding domain. J. Biol. Chem. 268:18549.
6. Monteclaro, F. S., and I. F. Charo. 1996. The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-1α receptor, confers chemokine selectivity: evidence for a two-step mechanism for MCP-1 receptor activation. J. Biol. Chem. 271:19084.
7. Pease, J. E., J. Wang, P. D. Ponath, and P. M. Murphy. 1998. The N-terminal extracellular segments of the chemokine receptors CCR1 and CCR3 are determinants for MIP-1α and eotaxin binding, respectively, but a second domain is essential for efficient receptor activation. J. Biol. Chem. 273:19972.
8. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872.
9. Wu, L., G. LaRosa, N. Kassam, C. J. Gordon, H. Heath, N. Ruffing, H. Chen, J. Humblias, M. Samson, M. Parmentier, et al. 1997. Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. J. Exp. Med. 186:1373.
10. Farzan, M., H. Choe, L. Vaca, K. Martin, Y. Sun, E. Desjardins, N. Ruffing, L. Wu, R. Wyatt, N. Gerard, et al. 1998. A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type I entry and mediates an association between gp120 and CCR5. J. Virol. 72:1160.
11. Garzino-Demo, A., A. L. DeVico, and R. C. Gallo. 1998. Chemokine receptors and chemokines in HIV infection. J. Clin. Immunol. 18:243.
12. Hoffman, T. L., and R. W. Doms. 1998. Chemokines and coreceptors in HIV/SIV-host interactions. AIDS 12:S17.
13. Berger, E. A., P. M. Murphy, and J. M. Farber. 1999. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17:657.
14. Lehner, T. 2002. The role of CCR5 chemokine ligands and antibodies to CCR5 coreceptors in preventing HIV infection. Trends Immunol. 23:347.
15. Atchison, R. E., J. Gosling, F. S. Monteclaro, C. Franci, L. Digilio, I. F. Charo, and M. A. Goldsmith. 1996. Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines. Science 274:1924.
16. Rucker, J., M. Samson, B. J. Doranz, F. Libert, J. F. Berson, Y. Yi, R. J. Smyth, R. G. Collman, C. C. Broder, G. Vassart, et al. 1996. Regions in β-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell 87:437.
17. Yu, C. R., K. W. Peden, M. B. Zaitseva, H. Golding, and J. M. Farber. 2000. CCR9A and CCR9B: two receptors for the chemokine CCL25/TECK/Ckβ-15 that differ in their sensitivities to ligand. J. Immunol. 164:1293.
18. Gupta, S. K., and K. Pillarisetti. 1999. Cutting edge: CXCR4-Lo: molecular cloning and functional expression of a novel human CXCR4 splice variant. J. Immunol. 163:2368.
19. Charo, I. F., S. J. Myers, A. Herman, C. Franci, A. J. Connolly, and S. R. Coughlin. 1994. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc. Natl. Acad. Sci. USA 91:2752.
20. + individuals with a structural variant of the chemokine receptor CX3CR1. Science 287:2274.
21. Moatti, D., S. Faure, F. Fumeron, M. Amara, P. Seknadji, D. H. McDermott, P. Debre, M. C. Aumont, P. M. Murphy, D. de Prost, et al. 2001. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 97:1925.
22. Bazan, J. F., K. B. Bacon, G. Hardiman, W. Wang, K. Soo, D. Rossi, D. R. Greaves, A. Zlotnik, and T. J. Schall. 1997. A new class of membrane-bound chemokine with a CX3C motif. Nature 385:640.
23. Imai, T., K. Hieshima, C. Haskell, M. Baba, M. Nagira, M. Nishimura, M. Kakizaki, S. Takagi, H. Nomiyama, T. J. Schall, et al. 1997. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91:521.
24. + cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J. Immunol. 168:6173.
25. Nishiyori, A., M. Minami, Y. Ohtani, S. Takami, J. Yamamoto, N. Kawaguchi, T. Kume, A. Akaike, and M. Satoh. 1998. Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia? FEBS Lett. 429:167.
26. Meucci, O., A. Fatalis, A. A. Simen, and R. J. Miller. 2000. Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc. Natl. Acad. Sci. USA 97:8075.
27. Boehme, S. A., F. M. Lio, D. Maciejewski-Lenoir, K. B. Bacon, and P. J. Conlon. 2000. The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia. J. Immunol. 165:397.
28. Matloubian, M., A. David, S. Engel, J. E. Ryan, and J. G. Cyster. 2000. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat. Immunol. 1:298.
29. Pan, Y., C. Lloyd, H. Zhou, S. Dolich, J. Deeds, J. A. Gonzalo, J. Vath, M. Gosselin, J. Ma, B. Dussault, et al. 1997. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 387:611.
30. Fong, A. M., L. A. Robinson, D. A. Steeber, T. F. Tedder, O. Yoshie, T. Imai, and D. D. Patel. 1998. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J. Exp. Med. 188:1413.
31. Soriano, S. G., L. S. Amaravadi, Y. F. Wang, H. Zhou, G. X. Yu, J. R. Tonra, V. Fairchild-Huntress, Q. Fang, J. H. Dunmore, D. Huszar, et al. 2002. Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury. J. Neuroimmunol. 125:59.
32. Haskell, C. A., W. W. Hancock, D. J. Salant, W. Gao, V. Csizmadia, W. Peters, K, Faia, O. Fituri, J. B. Rottman, and I. F. Charo. 2001. Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection. J. Clin. Invest. 108:679.
33. Combadiere, C., S. Potteaux, J. L. Gao, B. Esposito, S. Casanova, E. J. Lee, P. Debre, A. Tedgui, P. M. Murphy, and Z. Mallat. 2003. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation 107:1009.
34. -/- mice reveals a role for fractalkine in atherogenesis. J. Clin. Invest. 111:333.
35. Rucker. J., A. L. Edinger, M. Sharron, M. Samson, B. Lee, J. F. Berson, Y. Yi, B. Margulies, R. G. Collman, B. J. Doranz, et al. 1997. Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses. J. Virol. 71:8999.
36. Reeves, J. D., A. McKnight, S. Potempa, G. Simmons, P. W. Gray, C. A. Power, T. Wells, R. A. Weiss, and S. J. Talbot. 1997. CD4-independent infection by HIV-2 (ROD/B): use of the 7-transmembrane receptors CXCR-4, CCR-3. and V28 for entry. Virology 231:130.
37. Combadiere, C., K. Salzwedel, E. D. Smith, H. L. Tiffany, E. A. Berger, and P. M. Murphy. 1998. Identification of CX3CR1: a chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1. J. Biol. Chem. 273:23799.
38. McDermott, D. H., J. S. Colla, C. A. Kleeberger, M. Plankey, P. S. Rosenberg, E. D. Smith, P. A. Zimmerman, C. Combadiere, S. F. Leitman, R. A. Kaslow, et al. 2000. Genetic polymorphism in CX3CR1 and risk of HIV disease. Science 290:2031.
39. Hendel, H., C. Winkler, P. An, E. Roemer-Binns, G. Nelson, P. Haumont, S. O'Brien, K. Khalilli, D. Zagury, J. Rappaport, et al. 2001. Validation of genetic case-control studies in AIDS and application to the CX3CR1 polymorphism. J. Acquired Immune Defic. Syndr. 26:507.
40. Porzio, M. A., and A. M. Pearson. 1977. Improved resolution of myofibrillar proteins with sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Biochim. Biophys. Acta 490:27.
41. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:3440.
42. Sol, N., F. Ferchal, J. Braun, O. Pleskoff, C. Treboute, I. Ansart, and M. Alizon. 1997. Usage of the coreceptors CCR-5, CCR-3, and CXCR-4 by primary and cell line-adapted human immunodeficiency virus type 2. J. Virol. 71:8237.
43. Garin, A., P. Pellet, P. Deterre, P. Debre, and C. Combadiere. 2002. Cloning and functional characterization of the human fractalkine receptor promoter regions. Biochem. J. 368:753.
44. Kozak, M. 1997. Recognition of AUG and alternative initiator codons is augmented by G in position +4 but is not generally affected by the nucleotides in positions +5 and +6. EMBO J. 16:2482.
45. 2-terminal domain of CC chemokine receptor 5 contribute to high affinity binding of chemokines. J. Exp. Med. 194:1661.
46. Kozak, M. 1996. Interpreting CDNA sequences: some insights from studies on translation, Mamm. Genome. 7:563.
47. Fong, A. M., S. M. Alam, T. Imai, B. Haribabu, and D. D. Patel. 2002. CX3CR1 tyrosine sulfation enhances fractalkine-induced cell adhesion. J. Biol. Chem. 277:19418.
48. Moore, J. P. 1997. Coreceptors: implications for HIV pathogenesis and therapy. Science 276:51.
49. Farzan, M., T. Mirzabekov, P. Kolchinsky, R. Wyatt, M. Cayabyab, N. P. Gerard, C. Gerard, J. Sodroski, and H. Choe. 1999. Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell 96:667.